Epoetin dosing and dialysis facility ownership.
Regidor
Deborah L
DL
Kalantar-Zadeh
Kamyar
K
Kovesdy
Csaba P
CP
D000554:Ambulatory Care Facilities / Q000458:organization & administration; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D010067:Ownership; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects / Q000592:standards; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000628:therapy*; D014481:United States
D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa